Sign inJoin waitlistJoin the waitlist

George Blumenschein

Professor · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
1997–2000
Internal Medicine
University of Texas Health Science Center at Houston
1994–1997
McGovern Medical School at The University of Texas Health Science Center at Houston
1990–1994

Research

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 7,953 citations
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2016 · 4,100 citations
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 2,096 citations

John Heymach
40 papers
Frank Fossella
36 papers
Anne Tsao
31 papers · 1 as a fellow
Aman Buzdar
26 papers
Gabriel Hortobagyi
26 papers
Don Gibbons
22 papers
RH
Roy Herbst
22 papers
Mehmet Altan
21 papers
BG
Bonnie Glisson
20 papers
Charles Lu
20 papers
Jianjun Zhang
19 papers
JL
Joanna Lee
19 papers · 7 as a resident

Clinical trials

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2016–2026
RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
2010–2014
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2007–2026
BATTLE Program: Sorafenib in Patients With NSCLC
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2006–2012